Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: J Cyst Fibros. 2021 May 31;21(1):143–145. doi: 10.1016/j.jcf.2021.05.004

Table 1:

Summary of key study endpoints. N = number of paired data points. WL = whole lung; CC60-90 = cough assisted clearance between 60-90 min; C/P = central/peripheral; CL = central lung; PL = peripheral lung; FeNO = fractional exhaled NO. Listed p values are not corrected for multiple comparisons.

Variable N Baseline 1-month Paired t-test
P-values
Sweat Chloride - mEq/L 24 99.4 ± 9.0 81.6 ± 12.0 1.8E-07
FEV1 - L 25 2.53 ± 0.92 2.55 ± 0.96 0.70
FVC - L 25 3.34 ± 1.06 3.39 ± 1.06 0.42
FEV1 - % pred 25 77.2 ± 24.4 77.1 ± 23.9 0.98
FVC - % pred 24 86.9 ± 18.4 87.3 ± 15.8 0.75
FeNO 21 11.2 ± 6.5 12.3 ± 8.8 0.40
LCI2.5% 21 12.1 ± 5.3 11.8 ± 4.7 0.56
WL_Ave60 % 25 11.9 ± 10.4 10.6 ± 8.1 0.45
WL_Ave90 % 25 13.9 ± 11.4 13.2 ± 8.1 0.70
WL_24hr % 25 28.7 ± 18.2 30.2 ± 16.3 0.76
CC60-90 %/min 25 0.07 ± 0.24 0.21 ± 0.31 0.02
Deposition C/P ratio 25 2.37 ± 0.91 2.19 ± 0.65 0.26
Deposition skew 25 2.08 ± 1.65 1.76 ± 1.14 0.11
CL_Ave60 % 25 16.4 ± 14.7 16.5 ± 11.0 0.98
CL_Ave90 % 25 19.6 ± 15.6 20.5 ± 11.0 0.70
PL_Ave60 % 25 7.1 ± 5.9 5.7 ± 7.3 0.35
PL_Ave90 % 25 8.1 ± 6.4 7.3 ± 7.3 0.58